Comparison of Combined Spinal Epidural Analgesia and Erector Spinae Plane Block After Elective Cesarean Section
CSEA-ESP-CS
Comparison of the Postoperative Analgesic Effectiveness of Combined Spinal Epidural Analgesia and Erector Spinae Plane Block in Elective Cesarean Section
1 other identifier
interventional
90
1 country
1
Brief Summary
Postoperative pain after cesarean section can significantly affect maternal recovery, early mobilization, and patient satisfaction. Regional anesthesia techniques are widely used to improve postoperative analgesia and reduce opioid consumption. Combined spinal-epidural analgesia is commonly used for cesarean section and provides effective pain control but may be associated with technical difficulties and potential complications. The erector spinae plane block is a newer ultrasound-guided regional anesthesia technique that has shown promising results for postoperative pain management in various surgical procedures. The aim of this study is to compare the postoperative analgesic effectiveness of combined spinal-epidural analgesia and the erector spinae plane block in patients undergoing elective cesarean section. Pain intensity will be assessed using the visual analog scale at multiple postoperative time points. Maternal recovery will be evaluated using the Obstetric Quality of Recovery-11 questionnaire. Secondary outcomes will include postoperative nausea, pruritus, time to first analgesic request, mobilization time, and patient satisfaction. This study will help determine whether the erector spinae plane block can provide comparable or improved postoperative pain control with fewer complications compared to combined spinal-epidural analgesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2026
ExpectedFebruary 17, 2026
February 1, 2026
2 months
February 5, 2026
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Scores Assessed by Visual Analog Scale (VAS)
Postoperative pain intensity will be evaluated using the Visual Analog Scale (VAS) at 0, 1, 6, 12, and 24 hours after surgery. Dynamic VAS scores will also be recorded during movement.
0, 1, 6, 12, and 24 hours postoperatively
Secondary Outcomes (3)
Postoperative Recovery Quality Assessed by Obstetric Quality of Recovery-11 (ObsQoR-11)
Within the first 24 hours postoperatively
Time to First Analgesic Requirement
First 24 hours postoperatively
Postoperative Adverse Effects
Within the first 24 hours postoperatively
Study Arms (2)
Combined Spinal Epidural Analgesia Group
ACTIVE COMPARATORParticipants receive combined spinal-epidural analgesia for cesarean section anesthesia and postoperative pain management according to institutional protocol.
Erector Spinae Plane Block Group
ACTIVE COMPARATORParticipants receive spinal anesthesia for cesarean section followed by ultrasound-guided bilateral erector spinae plane block for postoperative analgesia.
Interventions
Combined spinal-epidural analgesia is performed for cesarean section anesthesia using standard institutional technique, providing intraoperative anesthesia and postoperative pain control through epidural catheter administration.
Bilateral ultrasound-guided erector spinae plane block is performed following spinal anesthesia for cesarean section to provide postoperative analgesia.
Eligibility Criteria
You may qualify if:
- Female patients aged 18-45 years
- Scheduled for elective cesarean section under regional anesthesia
- American Society of Anesthesiologists (ASA) physical status I-II
- Singleton pregnancy at term gestation
- Ability to understand the study protocol and provide written informed consent
You may not qualify if:
- Refusal to participate in the study
- Contraindications to regional anesthesia (coagulopathy, infection at injection site, severe hypovolemia)
- Known allergy to local anesthetics or study medications
- Body mass index (BMI) \> 40 kg/m²
- Chronic opioid use or chronic pain disorders
- Neurological disorders affecting sensory assessment
- Severe obstetric complications (e.g., preeclampsia, placenta previa, fetal distress)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa City Hospital
Bursa, Nilüfer, 16110, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Serra Topal
Bursa City Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesiology and Reanimation
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 17, 2026
Study Start
March 15, 2026
Primary Completion
May 15, 2026
Study Completion (Estimated)
August 15, 2026
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly due to institutional policies and patient confidentiality considerations.